| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.50B | +39.3% |
| Cost of Revenue | $1.41B | +39.0% |
| R&D Expense | $46.3M | +157.4% |
| SG&A Expense | $523.1M | +54.5% |
| Operating Income | $25.4M | -70.9% |
| Pre-tax Income | -$794K | -100.9% |
| Income Tax | -$17.0M | -172.9% |
| Net Income | $16.2M | -76.1% |
| EPS (Basic) | -$1.36 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $289.0M | +64.6% |
| Accounts Receivable | $177.2M | +65.7% |
| Inventory | $294.7M | +11.6% |
| Current Assets | $792.6M | +42.0% |
| Total Assets | $947.6M | +42.6% |
| Current Liabilities | $338.5M | +31.4% |
| Total Liabilities | $366.6M | +28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $99.4M | +41.3% |
| Capital Expenditures | $20.5M | +0.2% |
| Investing Cash Flow | -$39.8M | -94.6% |
| Financing Cash Flow | $53.7M | +1951.5% |
| Free Cash Flow | $78.9M | +58.2% |
| -389.4% |
| EPS (Diluted) | -$1.36 | -389.4% |
| Stockholders' Equity |
| $581.0M |
| +434.4% |